study, simvastatin upregulated BDNF expression and restored the BDNF level in the MPTP-treated striatonigral regions. These findings suggest that simvastatin's neuroprotection may be linked to the upregulation of BDNF via activation of PPARα, and it could be a possible therapeutic intervention for the treatment of PD.
Bohara et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: